|
|
||||||||
Ann Thorac Surg 1989;47:907-913
© 1989 The Society of Thoracic Surgeons
Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts USA
Accepted for publication January 25, 1989.
* Address reprint requests to Dr Daggett, Department of Surgery, Massachusetts General Hospital, Boston, MA 02114.
This study investigates whether the addition of magnesium to a hyperkalemic cardioplegic solution containing 0.1 mM ionized calcium improves myocardial preservation, and whether there is an optimal magnesium concentration in this solution. Isolated perfused rat hearts were arrested for two hours by this cardioplegic solution, which was fully oxygenated and infused at 8 °C every 15 minutes to simulate clinical conditions. The cardioplegic solution contained either 0, 2, 4, 8, 16, or 32 mM magnesium. At end-arrest, the myocardial creatine phosphate concentration (nanomoles per milligram of dry weight) was 20.7 ± 2.1, 22.9 ± 1.7, 24.8 ± 2.0, 31.3 ± 1.4, 33.1 ± 1.8, and 31.6 ± 0.8, respectively, in hearts given cardioplegic solution containing these magnesium concentrations. Thus, the concentration of creatine phosphate was significantly higher at end-arrest when the cardioplegic solution contained 8, 16, or 32 mM than 0 or 2 mM magnesium (p < 0.002) or 4 mM magnesium (p < 0.02), and highest with 16 mM magnesium. Also, creatine phosphate was more sensitive to the magnesium concentration of the cardioplegic solution than was end-arrest adenosine triphosphate levels, which did not differ among the experimental groups. Aortic flow, expressed as a percentage of prearrest aortic flow, was 60.3 ± 5.0, 70.2 ± 5.5, 71.6 ± 4.4, 71.8 ± 4.8, 81.0 ± 5.0, and 71.8 ±5.3, respectively. The addition of magnesium to the cardioplegic solution improved recovery of aortic flow (p < 0.05, 16 mM versus 0 mM magnesium). We conclude from these data that with deep myocardial hypothermia and at an ionized calcium concentration of 0.1 mM, the addition of magnesium, over a broad concentration range, improved preservation of myocardial creatine phosphate and, at a concentration of 16 mM, improved aortic flow. The optimal magnesium concentration in the cardioplegic solution was 16 mM.
This article has been cited by other articles:
![]() |
J. R. Lopez, R. Jahangir, A. Jahangir, W. K. Shen, and A. Terzic POTASSIUM CHANNEL OPENERS PREVENT POTASSIUM-INDUCED CALCIUM LOADING OF CARDIAC CELLS: POSSIBLE IMPLICATIONS IN CARDIOPLEGIA J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 820 - 831. [Abstract] [Full Text] |
||||
![]() |
J. Caspi, E. Rudis, I. Bar, T. Safadi, and M. Saute Effects of magnesium on myocardial function after coronary artery bypass grafting Ann. Thorac. Surg., April 1, 1995; 59(4): 942 - 947. [Abstract] [PDF] |
||||
![]() |
M. R. England, G. Gordon, M. Salem, and B. Chernow Magnesium Administration and Dysrhythmias After Cardiac Surgery: A Placebo-Controlled, Double-blind, Randomized Trial JAMA, November 4, 1992; 268(17): 2395 - 2402. [Abstract] [PDF] |
||||
![]() |
G. A. Geffin, T. R. Reynolds, J. S. Titus, D. D. O'Keefe, and W. M. Daggett Relation of myocardial protection to cardioplegic solution pH: Modulation by calcium and magnesium Ann. Thorac. Surg., October 1, 1991; 52(4): 955 - 964. [Abstract] [PDF] |
||||
![]() |
P. S. Brown Jr, F. W. Holland, G. L. Parenteau, and R. E. Clark Magnesium ion is beneficial in hypothermic crystalloid cardioplegia Ann. Thorac. Surg., March 1, 1991; 51(3): 359 - 367. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |